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Summary
Saccharomyces cerevisiae is an excellent model organism for studies of transcriptional regu-
lation of metabolic processes in other eukaryotic cells including human cells. Cellular acid-
-base balance can be disturbed in pathologic situations such as renal acidosis or cancer. The 
extracellular pH of malignant solid tumors is acidic in the range of 6.5-6.9. EG07 and EG37 aci 
mutants of Saccharomyces cerevisiae excessively excrete carboxylic acids to glucose-containing 
media or distilled water. The excreted acids are Krebs and/or glyoxylate cycle intermediates. 
The genes restoring the wild-type phenotype have function that does not easily explain the 
Aci+ phenotype.
In this study, using real-time PCR we measured relative mRNA expression, in the mutants 
compared to the wild-type strain, of selected genes associated with both carboxylic acid cycles 
and two cell transporters, Pma1 and Pdr12, of organic acids.
Unexpectedly, we found that the relative expression of the selected Krebs cycle and glyoxylate 
cycle genes did not change significantly. However, the expression of the two transporter genes 
was strongly elevated in EG37 and moderately increased in EG07.
These results indicate that the induction of the two cell transporter genes plays an important 
role in acid excretion by the aci mutants.
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IntroductIon
The yeast Saccharomyces cerevisiae is an excellent model 
organism for studies of transcriptional regulation of me-
tabolic processes, such as Krebs cycle, glyoxylate cycle 
or cellular transport of organic acids in eukaryotic cells 
[10,12,13,17,21]. For example, such model studies may 
be very helpful in finding molecular mechanisms that 
explain metabolic acidosis in renal cells [18] or how solid 
tumors generate acid and export it into the surrounding 
parenchyma [24]. The entire genome of S. cerevisiae was 
sequenced in 1996 [7]. However, despite a broad know-
ledge of many metabolic reactions in this organism, the 
transcriptional regulation of the metabolic pathways, 
including the ones named above, is complex and rema-
ins unclear [6]. Metabolic mutants like those defective 
in Krebs cycle genes [1,23] have been very useful in this 
kind of research. Gonchar et al. [8] using a mutagenic re-
agent ethyl methanesulfonate (EMS) generated a group 
of S. cerevisiae aci mutants that on complete Kok medium 
[11] containing glucose excrete acids. The excreted acids 
were later identified as intermediates of the Krebs cycle 
or the glyoxylate cycle [2,16]. Quick release of acid was 
also observed when the mutants were suspended in water 
[16]. The aci mutants were found to be the result of single 
gene mutations and distributed among 16 complemen-
tation groups [9]. Transformation of the mutants with a 
genomic DNA library on the multicopy shuttle plasmid 
pFL44L [3] restored the wild-type Aciˉ [2]. Also, in our 
preliminary studies (unpublished results) a single-co-
py plasmid containing the YLR376C gene had this ability. 
Overall, three genes, YJL185C, YLR376C and YJR129C, re-
storing the Aciˉ phenotype were identified. YJL185C en-
codes Pex3p interacting protein required for pexophagy 
(www.yeastgenome.org). YLR376C encodes a component 
of the Shu complex, which promotes error-free DNA re-
pair (www.yeastgenome.org). YJR129C encodes a putati-
ve adenosylmethionine-dependent methyltransferase 
(www.yeastgenome.org) [2]. However, the functions of 
these proteins do not easily explain the Aci+ phenotype. 
Presumably, the discovered genes play unknown regula-
tory roles that indirectly influence the function of the 
Krebs and/or glyoxylate cycle. In such a case the exces-
sive accumulation of the organic acids in the cytoplasm 
induces an acid stress response that leads to the removal 
of the acids from the cell. Another possibility is that the 
mutated genes regulate the expression or activity of an 
organic anion transporter such as Pdr12 cooperating with 
a proton pump such as Pma1 [21].
Our ultimate goal is the identification of the mutated 
genes, and genetic cascades with corollary metabolic 
pathways triggered by the mutations. However, before 
the attainment of this goal we decided to broaden bio-
chemical characterization of the aci mutants. In this 
study, using a real-time PCR technique, we compared 
mRNA expression of several important metabolic ge-
nes in two selected aci mutants to that in the wild-type 
strain D273-10B/A1 of S. cerevisiae. The two selected aci 
mutants, EG07 and EG37, display the strongest aci cha-
racter but differ in their growth ability on non-fermen-
table carbon sources [16]. The chosen metabolic genes 
encode enzymes of the Krebs and glyoxylate cycles, ABC 
anion transporter Pdr12 [21], proton pump Pma1 [25], 
and the transcription factor War1 that induces Pdr12 
activity [12].
MaterIals and Methods
Yeast strains
Saccharomyces cerevisiae strains, wild type and mutants, 
used in this work are listed in Table 1.
Table 1. Saccharomyces cerevisiae strains
Strains Markers Origin
Wild-type
D273-10B/A1
MATα met6
Dr. Grenson M., 
Universite Libre de 
Bruxelles, Belgium
Mutant
EG07
MATα met6
Dr. Boniewska-
Bernacka E.
University of Opole, 
Poland
Mutant
EG37
MATα met6
Dr. Boniewska-
Bernacka E. 
University of Opole, 
Poland
Growth conditions
The yeast cells were maintained on YPD (yeast extract 
1%, bacto-peptone 1%, dextrose 2%) agar slopes at 4°C, 
and cultivated 24 hours at 28°C in liquid YPD medium 
with shaking.
Aci+ – mutant phenotype excreting acids; aci – mutated gene; Cit1, Cit2 and Cit3 – citrate syntha-
se isozymes; ICL1 – isocitrate lyase isozyme; MDH1, MDH2 and MDH3 – malate dehydrogenase 
isozymes; PDR12 – plasma membrane ABC transporter; PMA1 – plasma membrane H+-ATPase; 
R – relative expression ratio: mutant/wild type; WAR1 – transcription factor of PDR12.
Abbreviations: 
Ewa Boniewska-Bernacka dr, Department of Biotechnology and Molecular Biology, University of Opole, 
Kominka 6, 45-032 Opole, Poland ; e-mail:boniesia@uni.opole.pl
Author’s address: 354
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PolyA+ mRNA isolation
Total RNA was extracted from yeast cells using a Total 
RNA kit (A&A Biotechnology, Gdansk, Poland) according 
to the manufacturer’s protocol. PolyA+ mRNA purification 
was performed using FastTrack® MAG mRNA Isolation Kits 
(Invitrogen, Carlsbad, CA, USA). Reverse transcription 
was performed using SuperScriptTM III Platinum® RT-
-PCR System (Invitrogen) in a total volume of 20 μl, then 
obtained cDNA was used to analyze gene expression by 
real-time PCR.
Real-time PCR assay
The PCR primers (Table 2) were custom synthesized by 
the DNA Sequencing and Oligonucleotide Synthesis La-
boratory at the Institute of Biochemistry and Biophysics, 
Polish Academy of Sciences, Warsaw, Poland (www.oli-
go.pl). The synthetic oligonucleotides were purified by 
HPLC. The gene specificity of the primers was checked by 
searching the Saccharomyces Genome Database at www.
yeastgenome.org with the Wu-BLAST2 program available 
on the same Internet site.
Gene Primers Sequence 5’→ 3’
Amplicon size 
(bp)
MDH1
sense GGGTTTACTCCAGAAGAGC
147
antisense TGCCAAATCGCGAACGATGC
MDH2
sense AAGAAAACCTGGCATGACTC
162
antisense ATGTTAGAAACCATCACTGG
MDH3
sense AGGCATTGGTAAGGATTTATC
143
antisense CTCTAGTTAAACCGGGCTTTC
PDR12
sense GTCGTTGAATCTGGTGAAATG
153
antisense AGACATCATTTCGCTTTGGTC
PMA1
sense TACAAACTGACCCATCTTACG
155
antisense AGCGGCTTCCATAACGAATTG
CIT1
sense ACTTCAACCGATCCTAATGC
162
antisense GGCAGAACCCACTAAATGTG
CIT2
sense GACCCAAATGCCGATTATGC
158
antisense GATAGTGCTGAGCCCACAAG
CIT3
sense CAGTCAATGTTTTGGCAAGG
177
antisense TTGCTGGAAAGTTGGCACAC
ICL1
sense GCATCAGGACAAGAACTAGC
170
antisense TGGGATGTTTCAGTCAATGG
WAR1
sense TGATGAGGAAACACAGAACG
148
antisense CCAAGTGTCAAGCTTCATCG
ACT1
sense TCTCCACCACTGCTGAAAGAG
149
antisense AGTGATGACTTGACCATCTGG
PDA1
sense TCGTGTTTTGCTGTGAGAAC
156
antisense TAGCAAACTTGGATGCTTGG
Table 2. Real-time PCR primers355
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Real-time PCR was performed using an ABI Prism 7900HT 
Sequence Detection System (Applied Biosystems, Foster 
City, CA, USA) in the presence of SYBR Green. Individual 
real-time PCR reactions were carried out in a 96-well pla-
te containing 10 μl of 2x SYBR Green Master Mix, 10 μl of 
0.25 μM primers (Table 2) and 5 μl of cDNA template. All 
reactions were performed using SYBR Green Two-Step 
qPCR-PCR Kit with ROX (Invitrogen). We used the PDA1 
gene as a primary endogenous control to standardize the 
amount of cDNA added to the reactions. The PCR reac-
tions of target genes were run in triplicate or occasional-
ly in duplicate. The duplicates were accepted only if the 
obtained Ct values were very similar (with a deviation 
less than 0.40 from the average, and only one duplicate 
had a Ct deviation of 0.72). The endogenous controls had 
4 or 5 data points. The PCR amplification protocol was as 
follows: incubation of reaction mixture at 50°C for 2 mi-
nutes, the initial denaturation step at 95°C for 2 minutes, 
then 40 cycles of heating and cooling at 95°C for 15 se-
conds and 60°C for 1 minute, respectively. After the runs, 
melting curves were analyzed to check if dimer primers 
or unspecific products were formed.
The ∆∆Ct [15,28] and Pfaffl methods [20,28] were used to 
calculate relative amounts (R or LogR values) of mutan-
t’s mRNA vs. wild strain’s mRNA normalized to the en-
dogenous reference (PDA1). Here the ∆∆Ct values were 
calculated from: ∆∆Ct = ∆Ctwild - ∆Ctmutant, where ∆Ct 
= Ctsample - CtPDA1. Both methods basically gave the 
same results except for ICL1, which displayed about 20% 
lower amplification efficiency than the other genes. To 
estimate experimental variability of the results, propaga-
ted standard deviations (SD) were calculated for the ∆∆Ct 
values, then the range of the relative expression ratios 
(Rmin to Rmax) was calculated using the E-∆∆Ct-SD and 
E-∆∆Ct+SD formulas [29] adjusted for the amplification 
efficiency if needed [15,29]. The Ct, ∆Ct and ∆∆Ct values 
were normalized for a constant efficiency (E) of 1.83 that 
was obtained for PDA1. The measured efficiencies were in 
the range of 1.82–1.94, except for the ICL1 efficiency of 
1.65. In addition, the standard statistical t-test was used 
for comparison of the means of the mutant’s and wild 
strain’s ∆Ct values.
results
Endogenous reference genes
To normalize the mRNA levels in different samples of the 
yeast strains we chose PDA1 as a reference gene. PDA1 is 
recommended here rather than ACT1 because it has been 
shown that in the case of S. cerevisiae, mRNA of PDA1 is 
expressed at a constant level over a longer period than 
that of ACT1, whose expression substantially drops when 
cultures of S. cerevisiae reach the stationary phase [27]. 
Anyway, we included ACT1 because this reference gene 
is frequently reported in the literature. The expression 
level of ACT1 vs. PDA1 in our mutants was somewhat hi-
gher than that in the wild strain, probably due to faster 
growth of the latter (data not shown).
Expression of selected structural genes associated 
with Krebs and glyoxylate cycles
Since the aci mutants excrete acids that are intermedia-
tes of the Krebs and glyoxylate cycles [16] we first exa-
mined several genes, CIT1, CIT2, CIT3, MDH1, MDH2, MDH3 
and ICL, of enzymes involved in these two cycles. The Cit 
and Mdh isozymes are the first and last enzymes in the 
two cycles, respectively, and changes in their expression 
levels could result in accumulation of the acidic inter-
mediates. These enzymes are often induced due to muta-
tion of other related metabolic genes [4,14] or changes of 
cell environmental conditions [14,19]. Cit1, Cit3 and Mdh1 
are the mitochondrial isozymes involved in the Krebs 
cycle. Cit2, Mdh2, and Icl1 are involved in the glyoxylate 
cycle, and Mdh3 is the peroxisomal isozyme. Somewhat 
surprisingly, the expression levels of these genes in the 
mutants, except for CIT3 in EG37 (3.7-fold increase), were 
not significantly different from those in the wild strain 
(Figures 1 and 2).
Fig. 1.  Relative expression of Krebs cycle genes; R, mRNA expression ratio 
relative to WT strain; WT, wild-type; EG07 and EG37, mutants; CIT1 and 
CIT3, genes coding citrate synthase isozymes 1 and 3; MDH1, gene coding 
malate dehydrogenase isozyme 1; Error bars represent propagated SD (see 
Materials and Methods); two asterisks denote t-test significance level at 
p<0.05 (see Materials and Methods).
Fig. 2.  Relative expression of glyoxylate cycle genes; CIT2, gene coding citrate 
synthase isozyme 2; MDH2 and MDH3, genes coding malate dehydrogenase 
isozymes 2 and 3; ICL1, gene coding isocitrate lyase isozyme 1; other 
symbols are the same as described in Fig. 1.356
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Expression of transporter genes, PDR12 and PMA1
PDR12 and PMA1 were included in the study because Piper 
et al. [21] reported that S. cerevisiae cultures incubated at 
pH 4.5 displayed 10-fold elevated PDR12 expression, when 
compared with pH 7.0 cultures. In the proposed mecha-
nism of anion extrusion by the Pdr12 transporter, the ac-
tivity of Pdr12 is postulated to be coupled to that of the 
Pma1 proton pump [21]. Since our mutants overproduce 
carboxylic acids, it was probable that the expression level 
of the two major acid transporters would increase relative 
to the wild strain. Indeed, this supposition has been con-
firmed in our experiments. The relative expression values 
(R) were 2.4 and 24 (0.38 and 1.38 on log scale) for PDR12 
in EG07 and EG37, respectively. The corresponding R va-
lues for PMA1 were 7.5 and 53 (0.88 and 1.72 on log scale), 
respectively (Figure 3). We also measured the expression 
level of WAR1 (Figure 3) encoding a transcription factor 
that mediates PDR12 induction [12]. The expression levels 
of WAR1 in the mutants were not significantly different 
from those in the wild strain (R values were 0.46 and 1.1 
for EG07 and EG37, respectively).
-type phenotype Aciˉ do not encode the enzymes of the 
two cycles and have functions not directly related to the 
acid excretion (www.yeastgenome.org) [2].
In this work we decided to investigate the mRNA expression 
of selected genes associated with both cycles in two mu-
tants displaying the strongest Aci+ phenotype. In addition, 
since the excretion of the acids involves membrane trans-
porters, two of them, Pdr12 and Pma1, extensively described 
in the literature, were included in the present studies. The 
two chosen aci mutants, EG07 and EG37, belong to diffe-
rent complementation groups [16] and therefore are assu-
med to have different mutated genes. Aside from the strong 
Aci+ phenotype, EG07 and EG37 are also interesting because 
they require very different growth conditions. EG37 easi-
ly utilizes non-fermentable substrates (except for ethanol) 
such as acetate but EG07 does not [16]. So, we expected to 
detect differences in regulation of both the cycles not only 
between each mutant and the wild strain but also betwe-
en the mutants themselves (EG07 and EG37). The selected 
CIT1, CIT2, CIT3, MDH1, MDH2, MDH3 and ICL genes encode 
important Krebs and glyoxylate cycle enzymes whose level 
can be expected to influence the kinetics of the two cycles. 
Since malate together with other carboxylic acid interme-
diates (citrate, succinate, and fumarate) accumulated to high 
concentrations in the medium [16] we first focused our at-
tention on MDH and CIT. Mdh is the last enzyme in the two 
cycles and it catalyzes the energetically unfavorable reac-
tion. The product oxalacetate has to be removed efficiently 
and therefore Mdh acts in a complex with Cit preventing 
excessive accumulation of oxalacetate [5,26]. Moreover, li-
terature data show that the expression of the genes selec-
ted here, including ICL1 associated with the glyoxylate cycle 
only, changes dramatically when glucose is replaced with 
non-fermentable substrates [19]. However, except for CIT3 
in EG37, our real-time PCR experiments did not reveal any 
significant expression changes of these genes between the 
studied strains (Figures 1 and 2). Only the R value for CIT3 
in EG37 was moderately elevated to 3.7 but we do not have 
a good explanation for this result. By contrast, we observed 
significant increases in the expression levels of the cell trans-
porter genes PDR12 and PMA1 in the mutants relative to the 
wild strain (Figure 3). Especially large R values of 24 and 53, 
respectively, were obtained for EG37. EG07 displayed mode-
rate R values of 2.4 and 7.5, respectively. The R value of 2.4 
is low and its significance at p < 0.1 questionable, but PDR12 
expression in EG07 might be higher at the protein level. It is 
probable that EG07 and EG37 have different mutations. This 
supposition is supported by the fact that these two mutants 
belong to different complementation groups [9] and behave 
differently with respect to acetate as a source of carbon. So 
far we have been mostly focusing our attention on genetic 
regulation of the Krebs and glyoxylate cycles and more stu-
dies are needed in this area, but the present results point to 
a different and probably more promising avenue of research 
dealing more with the regulation of the transporters rather 
than the enzymes of both cycles. After obtaining the first 
results for PDR12 and PMA1 we added WAR1 to our studies. 
PMA1 expression is known to be regulated by transcription 
factors Rap1 and Gcr1 [22], but first we focused our attention 
Fig. 3.  Relative expression of cell transporter genes PMA1, PDR12 and transcription 
factor gene WAR1; PMA1, gene coding Pma1 proton pump; PDR12, gene 
coding Pdr12 anion transporter; one and three asterisks denote t-test 
significance level at p<0.1 and p<0.01, respectively (see Materials and 
Methods); other symbols are the same as described in the previous figures.
dIscussIon
In our previous studies we isolated and biochemically cha-
racterized 16 S. cerevisiae mutants that excessively excre-
ted acidic intermediates of the Krebs and/or glyoxylate 
cycle. Genetic analysis indicated single mutation of dif-
ferent genes [9,16]. Since the acid excretion occurs in the 
presence of glucose, one could assume that the glyoxylate 
cycle is turned off. However, this is not necessarily true for 
the mutants; therefore we decided to include this cycle in 
our studies. Our primary supposition was that the excre-
tion of the organic acids was caused by a blockage of one 
of the cycles resulting in the accumulation of the acidic 
intermediates. However, there is no simple explanation 
for these findings because the genes restoring the wild-357
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on Pdr12, which transports organic anions. WAR1 is a gene 
encoding the transcription factor War1 of PDR12 [12]. We 
hoped that the expression of WAR1 at least in EG37 would 
be higher than that in the wild strain but only small diffe-
rences were observed. The R value for EG07 was even below 
one (0.46) with the 90% confidence level (Figure 3). Intere-
stingly, this result is consistent with the low expression of 
PDR12 in EG07 but further studies are necessary to exclude 
experimental coincidence. Anyway, such a result is not very 
surprising because literature data [12] suggest that War1 
requires phosphorylation for its activation, yet the kinase 
responsible for the phosphorylation is not known. At this 
moment, an unresolved question is whether the induction of 
PDR12 and PMA1 is caused by the accumulation of the acids in 
the mutant cells or by the mutation(s) of regulatory gene(s) 
associated with the transporters. This issue will be addressed 
in subsequent studies. In addition, we can conclude that one 
of the previously considered possibilities, that a physical le-
akage of the acids through the cell membrane is responsible 
for the Aci+ phenotype [16], should probably be excluded.
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